USPTO serial 86719803
GLIDE TECHNOLOGIES
Reviewed by CopyMark Law Group
Reg. 5184307Status 713
- Filing date
- Status date
- Registration date
- Apr 18, 2017
- Examiner
- ALI, STEPHANIE MARIE
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GLIDE TECHNOLOGIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Glide Pharmaceutical Technologies Limited
Abingdon, Oxfordshire, GB
Other trademarks owned by Glide Pharmaceutical Technologies Limited
Glide Pharmaceutical Technologies Limited
Abingdon, Oxfordshire, GB
Other trademarks owned by Glide Pharmaceutical Technologies Limited
Glide Pharmaceutical Technologies Limited
Abingdon, Oxfordshire, GB
Other trademarks owned by Glide Pharmaceutical Technologies Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark Harrison
GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED45B/C WESTERN AVENUEMILTON PARKABINGDON OXFORDSHIRE, OX144RUGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical, veterinary and agricultural preparations and substances given by injection for the diagnosis of, treatment of or protection against infectious diseases, pain, inflammation, sepsis, alopecia and obesity; pharmaceutical, veterinary and agricultural preparations and substances given by injection for the diagnosis of, treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; pharmaceutical, veterinary and agricultural preparations and substances for skin and tissue repair given by injection; prophylactic pharmaceutical, veterinary and agricultural preparations and substances given by injection; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substances; assays and reagents for diagnostic purposes, namely, viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders given by injection; assays and reagents for use in cancer diagnosis | SECTION 18 - CANCELLED | — |
| 010 | Medical and veterinary apparatus and instruments, namely, medical injectors, namely, injection devices for pharmaceuticals; drug delivery devices, namely, needle lancets, medical apparatus for injecting fluids and solids into a body, and parts and fittings; fluid and tissue sampling devices, namely, medical devices for obtaining body fluid samples, needle-free injectors; actuator devices for use in drug delivery devices, namely, medical fluid and medical solid injectors; drug cassettes for use in drug delivery devices to contain pharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; fluid and tissue sampling devices | SECTION 18 - CANCELLED | — |
| 042 | medical and veterinary device product development services, and information provided therewith; pharmaceutical product development services; pharmaceutical delivery system development services, namely, pharmaceutical drug development services, and information provided therewith; scientific research services into the preparation and/or formulation of pharmaceuticals; scientific research services in the field of medical and veterinary diagnostic services; medical and veterinary device and product testing services, and information provided therewith | SECTION 18 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Glide Pharmaceutical Technologies Limited
- Other trademarks owned by Glide Pharmaceutical Technologies Limited
- Other trademarks owned by Glide Pharmaceutical Technologies Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named GLIDE TECHNOLOGIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2019 | C18. | CANCELLED SECTION 18-TOTAL | — |
| Aug 13, 2019 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Aug 12, 2019 | CANG | CANCELLATION GRANTED NO. 999999 | — |
| Feb 4, 2019 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Apr 18, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 14, 2017 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Mar 7, 2017 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Mar 3, 2017 | APET | ASSIGNED TO PETITION STAFF | — |
| Feb 14, 2017 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Sep 21, 2016 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 23, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 23, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 3, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 20, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 16, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 25, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 25, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2016 | ALIE | ASSIGNED TO LIE | — |
| May 19, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 8, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2015 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| Dec 2, 2015 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Dec 2, 2015 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Dec 2, 2015 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Nov 30, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2015 | ALIE | ASSIGNED TO LIE | — |
| Nov 20, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 10, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 13, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 13, 2015 | NWAP | NEW APPLICATION ENTERED | — |